The Penn State Board of Trustees Committee on Academic Affairs, Research and Student Life recently reviewed the University’s efforts to expand its artificial intelligence (AI) initiatives, focusing on the Penn State College of Medicine’s evolving AI portfolio. At the forefront of these discussions were Dr. Karen Kim, the dean of the College of Medicine, and Dr. Dajiang Liu, a distinguished professor and director of bioinformatics and AI. They emphasized the College’s strategic approach to leverage AI in enhancing health outcomes, scientific discovery, operational efficiency, and administrative tasks. Highlighted strategies include utilizing predictive models for patient outcomes, advancing scientific research with AI, and improving faculty and staff efficiencies. The College has already made significant investments in AI, supporting various research projects aimed at improving diagnostics, preventative care, and treatment. Collaborative efforts extend across Penn State and with partners like Highmark Health, ensuring the College’s AI initiatives remain at the cutting edge of healthcare innovation.
Penn State College of Medicine Unveils AI Strategies to Revolutionize Healthcare
The Penn State College of Medicine is strategically leveraging AI to transform health outcomes and research.
TOP STORIES
Quantum computing is transforming industries, but it poses significant cybersecurity risks …
A coalition of state attorneys general has opened an investigation into OpenAI …
The U.S. government’s export control directive has forced Anthropic to disable its new AI models, raising questions about regulation and …
SpaceX’s recent deal with Google highlights its shift from aerospace to AI infrastructure …
Google is suing to dismantle the infrastructure behind an alleged massive AI-powered cybercrime operation …
AI usage continues to grow rapidly, even as public sentiment remains skeptical …
